Medicare Part B Drug Waste From Single-Dose Vials To Be Studied By OIG
Executive Summary
HHS watchdog suggests savings to Medicare Part B could be generated if manufacturers sold smaller-size vials at lower prices; Office of Inspector General will also consider potential savings from establishing inflation-based rebates in Part B.